United States · FDA National Drug Code directory
Rybrevant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-501_ce70b7e6-860b-49b8-8d74-c2a0f8c88c21
- Product NDC
- 57894-501
- Form
- INJECTION
- Composition / generic term
- amivantamab-vmjw
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20210521
- Source listing expiry
- 20271231
Source-listed ingredients
- AMIVANTAMAB — 350 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) / 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00) · 57894-501-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →